Overview
The PHC Group provides products and services for diabetes management, life sciences and diagnostics, as well as enhanced healthcare services that are used by patients, healthcare professionals and researchers in over 125 countries. By integrating digital solutions with our expertise in precision technology that has been nurtured over decades, we provide the best-in-class devices and services for advancing basic research, diagnosis and medical treatment.
Operations
*1 As of March 2020
*2 As of March 2020
Core Business Areas
The PHC Group offers products and services taking advantage of high technology with many major products enjoying significant market shares.
*1 Combined market share of Arkray and Sanwa
*2 Total market share of Ascensia Diabetes Care Holdings AG and other distributors
Note 2: Copyright © 2019 IQVIA., Reprinted with permission.
Note 3: The number of market share in Japan is calculated based on MIDAS 2017Q1-Q4 and estimated by in-house investigation.
Note 4: The number of global market share is based on aggregation of IQVIA MIDAS 2017 Q1-Q4 data and other syndicated sources.
Learn more about our diabetes care
*1 Source: “Latest Trends and Future Potentiality of Tissue Engineering Related Market 2019” by Fuji Keizai Co., Ltd. (based on 2018 performance by volume)
*2 Source: Research by Frost & Sullivan (Base: unit in FY2018)
Learn more about our life sciences products
*1 Source: Survey by Yano Research Institute Ltd. as of August 2019
*2 Source: Survey by Seed Planning 2011
Japan's First on Manufacturing and the Strengths of High Technology
The PHC Group leads the healthcare industry with innovative products, created with the foundation in manufacturing and high technology accumulated for over 50 years.
History of PHC Group